Cargando…
Frontiers in cardiovascular drug discovery. Volume 3 /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Sharjah :
Bentham Science Publishers,
2016.
|
| Colección: | Frontiers in Cardiovascular Drug Discovery.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- PREFACE; List of Contributors ; P2Y12-Receptor Antagonists and the Concept of Tailored Strategy ; INTRODUCTION; ADP RECEPTORS; P2Y12 RECEPTOR; P2Y12 INHIBITORS; Thienopyridines; Ticlopidine; Clopidogrel; Prasugrel; Ticagrelor; Cangrelor; Elinogrel; BX 667; THE CONCEPT OF PERSONALIZED THERAPY; Factors Influencing Clopidogrel Variability; Anti-Platelet Function Testing; Platelet Aggregometry; Flow Cytometry; Shear-Dependent Assay; Platelet Counting; Thrombelastography; Anti-Platelet Function Testing & Clinical Impact; Genotype Testing; Genetic Testing & Clinical Impact.
- Vasopressin and the Cardiovascular System: Receptor Physiology and Clinical Implications INTRODUCTION; HISTORICAL ASPECTS; PHYSIOLOGY OF VASOPRESSIN; Structure of Vasopressin and Related Peptides; Structure of Vasopressin; Structure of Related Peptides; Synthesis of Vasopressin; Metabolism; Factors Affecting Vasopressin Release; Osmoregulation; Baroregulation; Neurohormonal Stimuli; Plasma Levels of Vasopressin; Vasopressin Levels in Health; Vasopressin Levels During Illness; Measurement of Plasma Vasopressin Levels; Vasopressin Receptors; Receptor Structure; Receptor Subtypes; V1A Receptor.
- V1B€or V3 ReceptorV2€Receptor; Oxytocin Receptor; Purinergic Receptors; Down Regulation of Vasopressin Receptors; Systemic Effects of Vasopressin; Renal Effects; Vasoconstrictor Effects; Vasodilator Effects; Effects of Vasopressin on Heart; Endocrine Effects; Effects on Coagulation System; Other Effects; Therapeutic Applications of Vasopressin; Nocturnal Enuresis; Diabetes Insipidus; Bleeding Abnormalities; Oesophageal Varices Haemorrhage; Abdominal Distension & Abdominal X-ray; Vasodilatory Shock States; Hemorrhagic Shock; Other Uses; Future; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS.